Learn More
Medchemexpress LLC 5-(3-chloro-4-cyclohexylphenyl)-1-(3-methoxyphenyl)-1H-pyrazole-3-carboxylic acid | 1393814-38-4 | MFCD26792575 | 99.7% | 410.89 g·mol-1 | C23H23ClN2O3 | 10 MG

Supplier: Medchemexpress LLC HY10761510MG
TC LPA5 4 is a selective, non-lipid antagonist of the lysophosphatidic acid receptor 5 (LPA5/GPR92) used as a research tool to probe LPA5 signaling. It inhibits LPA-induced platelet aggregation (IC50 ≈ 0.8 μM) and has been reported to reduce proliferation and migration in certain cancer cell lines. The compound is provided with high reported purity and DMSO solubility for preparation of concentrated stock solutions.
- Selective LPA5 antagonist suitable for receptor signaling studies.
- Non-lipid, small-molecule antagonist with reported IC50 ~0.8 μM.
- Inhibits LPA-induced platelet aggregation and cell migration.
- High reported purity appropriate for biochemical and cell-based assays.
- High solubility in DMSO for convenient stock preparation.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.